HIV-related severe thrombocytopenia in intravenous drug users: Prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation

Giuseppe Landonio, Massimo Galli, Annamaria Nosari, Adriano Lazzarin, Dino Cipriani, Paolo Crocchiolo, Luca Voltolin, Fabio Giannelli, Laura Irato, Francesco De Cataldo, Mauro Moroni

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Severe thrombocytopenia (TP) accounted for 5.3% of cases in a consecutive series of 380 HIV-infected intravenous drug users (IVDUs) at presentation. Forty-one of 53 subjects with severe TP showed haemorrhages and were treated as follows: ten were splenectomized, 17 were given high-dose intravenous immunoglobulins (HDIg), and 10 received anti-Rh(D) immunoglobulins (anti-Rh Ig). Splenectomy induced a complete clinical response in all cases: four out of 10 patients maintained platelet counts >100 × 109/I. HDIg gave a good clinical response in all patients, but eight out of 17 suffered haemorrhages during the follow-up and recall treatments were necessary. Six out of 10 patients treated with anti-Rh Ig maintained platelet counts >30 × 109/I, but in two cases the treatment was interrupted because of severe haemolysis. No patient progressed to overt AIDS during the follow-up. Splenectomized patients in particular did not show adjunctive risks of worsening of the HIV-related clinical picture. A platelet kinetic study performed in 20 patients with severe HIV-related TP suggests a possible role for platelet sequestration in TP of HIV-infected IVDUs, in which a liver involvement is very frequent.

Original languageEnglish
Pages (from-to)29-34
Number of pages6
JournalAIDS (London, England)
Volume4
Issue number1
Publication statusPublished - 1990

Fingerprint

Drug Users
Thrombocytopenia
HIV
Rho(D) Immune Globulin
Intravenous Immunoglobulins
Platelet Count
Therapeutics
Blood Platelets
Hemorrhage
Splenectomy
Hemolysis
Acquired Immunodeficiency Syndrome
Liver

Keywords

  • Anti-Rh(D) immunoglobulins
  • High-dose immunoglobulins
  • Intravenous drug users
  • Platelet kinetic study
  • Severe HIV-related thrombocytopenia
  • Splenectomy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Landonio, G., Galli, M., Nosari, A., Lazzarin, A., Cipriani, D., Crocchiolo, P., ... Moroni, M. (1990). HIV-related severe thrombocytopenia in intravenous drug users: Prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation. AIDS (London, England), 4(1), 29-34.

HIV-related severe thrombocytopenia in intravenous drug users : Prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation. / Landonio, Giuseppe; Galli, Massimo; Nosari, Annamaria; Lazzarin, Adriano; Cipriani, Dino; Crocchiolo, Paolo; Voltolin, Luca; Giannelli, Fabio; Irato, Laura; De Cataldo, Francesco; Moroni, Mauro.

In: AIDS (London, England), Vol. 4, No. 1, 1990, p. 29-34.

Research output: Contribution to journalArticle

Landonio, G, Galli, M, Nosari, A, Lazzarin, A, Cipriani, D, Crocchiolo, P, Voltolin, L, Giannelli, F, Irato, L, De Cataldo, F & Moroni, M 1990, 'HIV-related severe thrombocytopenia in intravenous drug users: Prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation', AIDS (London, England), vol. 4, no. 1, pp. 29-34.
Landonio, Giuseppe ; Galli, Massimo ; Nosari, Annamaria ; Lazzarin, Adriano ; Cipriani, Dino ; Crocchiolo, Paolo ; Voltolin, Luca ; Giannelli, Fabio ; Irato, Laura ; De Cataldo, Francesco ; Moroni, Mauro. / HIV-related severe thrombocytopenia in intravenous drug users : Prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation. In: AIDS (London, England). 1990 ; Vol. 4, No. 1. pp. 29-34.
@article{f5088cc37064443f968f88dd1a952e97,
title = "HIV-related severe thrombocytopenia in intravenous drug users: Prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation",
abstract = "Severe thrombocytopenia (TP) accounted for 5.3{\%} of cases in a consecutive series of 380 HIV-infected intravenous drug users (IVDUs) at presentation. Forty-one of 53 subjects with severe TP showed haemorrhages and were treated as follows: ten were splenectomized, 17 were given high-dose intravenous immunoglobulins (HDIg), and 10 received anti-Rh(D) immunoglobulins (anti-Rh Ig). Splenectomy induced a complete clinical response in all cases: four out of 10 patients maintained platelet counts >100 × 109/I. HDIg gave a good clinical response in all patients, but eight out of 17 suffered haemorrhages during the follow-up and recall treatments were necessary. Six out of 10 patients treated with anti-Rh Ig maintained platelet counts >30 × 109/I, but in two cases the treatment was interrupted because of severe haemolysis. No patient progressed to overt AIDS during the follow-up. Splenectomized patients in particular did not show adjunctive risks of worsening of the HIV-related clinical picture. A platelet kinetic study performed in 20 patients with severe HIV-related TP suggests a possible role for platelet sequestration in TP of HIV-infected IVDUs, in which a liver involvement is very frequent.",
keywords = "Anti-Rh(D) immunoglobulins, High-dose immunoglobulins, Intravenous drug users, Platelet kinetic study, Severe HIV-related thrombocytopenia, Splenectomy",
author = "Giuseppe Landonio and Massimo Galli and Annamaria Nosari and Adriano Lazzarin and Dino Cipriani and Paolo Crocchiolo and Luca Voltolin and Fabio Giannelli and Laura Irato and {De Cataldo}, Francesco and Mauro Moroni",
year = "1990",
language = "English",
volume = "4",
pages = "29--34",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - HIV-related severe thrombocytopenia in intravenous drug users

T2 - Prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation

AU - Landonio, Giuseppe

AU - Galli, Massimo

AU - Nosari, Annamaria

AU - Lazzarin, Adriano

AU - Cipriani, Dino

AU - Crocchiolo, Paolo

AU - Voltolin, Luca

AU - Giannelli, Fabio

AU - Irato, Laura

AU - De Cataldo, Francesco

AU - Moroni, Mauro

PY - 1990

Y1 - 1990

N2 - Severe thrombocytopenia (TP) accounted for 5.3% of cases in a consecutive series of 380 HIV-infected intravenous drug users (IVDUs) at presentation. Forty-one of 53 subjects with severe TP showed haemorrhages and were treated as follows: ten were splenectomized, 17 were given high-dose intravenous immunoglobulins (HDIg), and 10 received anti-Rh(D) immunoglobulins (anti-Rh Ig). Splenectomy induced a complete clinical response in all cases: four out of 10 patients maintained platelet counts >100 × 109/I. HDIg gave a good clinical response in all patients, but eight out of 17 suffered haemorrhages during the follow-up and recall treatments were necessary. Six out of 10 patients treated with anti-Rh Ig maintained platelet counts >30 × 109/I, but in two cases the treatment was interrupted because of severe haemolysis. No patient progressed to overt AIDS during the follow-up. Splenectomized patients in particular did not show adjunctive risks of worsening of the HIV-related clinical picture. A platelet kinetic study performed in 20 patients with severe HIV-related TP suggests a possible role for platelet sequestration in TP of HIV-infected IVDUs, in which a liver involvement is very frequent.

AB - Severe thrombocytopenia (TP) accounted for 5.3% of cases in a consecutive series of 380 HIV-infected intravenous drug users (IVDUs) at presentation. Forty-one of 53 subjects with severe TP showed haemorrhages and were treated as follows: ten were splenectomized, 17 were given high-dose intravenous immunoglobulins (HDIg), and 10 received anti-Rh(D) immunoglobulins (anti-Rh Ig). Splenectomy induced a complete clinical response in all cases: four out of 10 patients maintained platelet counts >100 × 109/I. HDIg gave a good clinical response in all patients, but eight out of 17 suffered haemorrhages during the follow-up and recall treatments were necessary. Six out of 10 patients treated with anti-Rh Ig maintained platelet counts >30 × 109/I, but in two cases the treatment was interrupted because of severe haemolysis. No patient progressed to overt AIDS during the follow-up. Splenectomized patients in particular did not show adjunctive risks of worsening of the HIV-related clinical picture. A platelet kinetic study performed in 20 patients with severe HIV-related TP suggests a possible role for platelet sequestration in TP of HIV-infected IVDUs, in which a liver involvement is very frequent.

KW - Anti-Rh(D) immunoglobulins

KW - High-dose immunoglobulins

KW - Intravenous drug users

KW - Platelet kinetic study

KW - Severe HIV-related thrombocytopenia

KW - Splenectomy

UR - http://www.scopus.com/inward/record.url?scp=0025164735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025164735&partnerID=8YFLogxK

M3 - Article

C2 - 2156528

AN - SCOPUS:0025164735

VL - 4

SP - 29

EP - 34

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 1

ER -